Trials / Completed
CompletedNCT04719377
A Clinical Trial Evaluating the Effectiveness and Safety of the PowerMe Midline Catheter in the Chinese Population
A Prospective, Multi-center, Open-label, Randomized, Controlled Non-inferiority Clinical Trial Evaluating the Effectiveness and Safety of the PowerMe Midline Catheter Versus Traditional PIV in the Chinese Population
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 256 (actual)
- Sponsor
- Becton, Dickinson and Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to evaluate the effectiveness and the safety of the PowerMeTM Midline Catheter in the Chinese population.
Detailed description
This is a prospective, multi-center, open-label, randomized, controlled, non-inferiority clinical trial designed to evaluate the effectiveness and the safety of the PowerMeTM Midline Catheter compared to PIVC in the Chinese population in order to support the product's registration in China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | catheter placement | catheter placement |
Timeline
- Start date
- 2021-01-13
- Primary completion
- 2022-01-30
- Completion
- 2022-01-30
- First posted
- 2021-01-22
- Last updated
- 2022-09-23
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04719377. Inclusion in this directory is not an endorsement.